Myeloid-derived suppressor cells: Ductile targets in disease

Keyphrases

• Monocytic Myeloid-derived Suppressor Cells (M-MDSCs) 100%
• Myeloid Cells 50%
• Autoimmune Disease 33%
• Bone Marrow 16%
• Human Tumors 16%
• Anticancer Therapy 16%
• Regulatory Function 16%
• Potential Therapeutics 16%
• Inflammatory Process 16%
• Therapeutic Implications 16%
• Suppression Mechanism 16%
• Tumor Microenvironment 16%
• Cell Reprogramming 16%
• Immune Surveillance 16%
• Murine Tumors 16%
• Cell Expansion 16%
• Tumor Cytotoxicity 16%
• Adoptive Transfer 16%
• Multi-step Process 16%
• Myelopoiesis 16%
• Heterogeneous Population 16%
• Ductility 16%
• Immature Myeloid Cells 16%
• State of Emergency 16%
• Immunological Stress 16%
• Immunosuppressive Phenotype 16%

Immunology and Microbiology

• Myeloid-Derived Suppressor Cell 100%
• Myeloid 66%
• Immunosuppressive Drug 16%
• Cytotoxicity 16%
• Autoimmune Disease 16%
• Autoimmunity 16%
• Infectious Disease 16%
• Cell Expansion 16%
• Immunosurveillance 16%
• Nuclear Reprogramming 16%
• Myelopoiesis 16%
• Infection 16%